Botulinum toxin: what it is and how it is indicated

Botulinum toxin: what it is and where it comes from

What botulinum toxin does is one of the most searched questions before booking a first aesthetic medicine appointment. That makes sense: it is a molecule with an imposing name, a long pharmacological history, and a widespread use that sometimes generates more rumor than information. Here we explain what the evidence says, what remains under study, and where the real limits are.

Botulinum toxin is a protein produced by the bacterium Clostridium botulinum. In its clinical form, the version used in medicine is a purified fraction of that protein, formulated in precise doses for local application. It has nothing in common, in concentration or in effect, with the foodborne illness that shares the same name at its origin.

Botulinum toxin and Botox: are they the same thing?

In everyday conversation, botulinum toxin and Botox are used interchangeably. Technically they are not: Botox is a commercial brand of type A botulinum toxin, the first to obtain regulatory approval and the one that introduced the term into common language. Other registered brands of type A botulinum toxin are available in Mexico, though we do not name them here because the indication, dosage, and technique are decisions made at medical assessment, not by trade name.

What matters is understanding that all these formulations share the same mechanism: they temporarily block the nerve signal that instructs a muscle to contract. That block is local, reversible, and dose-dependent. The molecule does not travel to the rest of the body when it is applied correctly to the indicated area.

The indication, dosage, and technique are decisions made at medical assessment, not by trade name.

What botulinum toxin does in aesthetic medicine

Botulinum toxin works by transiently relaxing the facial expression muscles. When those muscles contract repeatedly over the years, the overlying skin accumulates folds that become fixed with time: the so-called dynamic expression lines. The most widely accepted aesthetic indication is softening those lines in areas where muscular movement is the primary factor.

The three areas with the strongest support in aesthetic use are:

• Forehead lines: the horizontal lines that appear when the eyebrows are raised.
• Glabellar lines: the vertical folds between the eyebrows, also called frown lines or "eleven lines."
• Periocular lines: the lines radiating from the outer corner of the eye, commonly known as crow's feet.

In these three areas, the available evidence describes a visible reduction in active expression lines. In static lines, those that remain when the face is at rest, the effect is smaller and depends on the depth of the fold and the quality of the skin.

Botulinum toxin softens dynamic expression lines. With deep static lines, no one can promise the same result.

How dosage and treatment area are decided at assessment

The dosage of botulinum toxin is not the same for every person. It is determined at a medical assessment that considers individual muscular anatomy, line depth, facial symmetry, muscle tone, and the objective the person describes. There is no universal dosage table: the same area may require different amounts depending on the patient.

The assessment involves analyzing the face at rest and in movement. The muscles involved, their contraction force, and the relationship between them are identified. This allows a protocol of areas and intensities to be designed with the aim of achieving a result that looks natural, not frozen. The plan is provided in writing.

The application generally consists of intradermal or intramuscular microinjections with a fine needle at the anatomical points defined in that assessment. The number of points and the amount per point depend on the individual protocol. The effect is not immediate: the muscle takes several days to respond, and the result develops gradually.

flowchart TD
    A["Initial consultation or remote assessment"] --> B["Facial analysis: at rest and in movement"]
    B --> C["Identification of muscles and objectives"]
    C --> D["Individual protocol design"]
    D --> E["Written plan: areas, dosage, follow-up"]
    E --> F["Application session under medical supervision"]
    F --> G["Follow-up: outcome evaluation"]
    G --> H{"Adjustment needed?"}
    H -->|"Yes"| I["Protocol adjustment at assessment"]
    H -->|"No"| J["Continuation of individual plan"]

When botulinum toxin is not indicated

Botulinum toxin has clear contraindications. It is not indicated during pregnancy or breastfeeding. It is also not applied in people with neuromuscular diseases such as myasthenia gravis or Lambert-Eaton syndrome, because the mechanism of action can worsen those conditions. Active infections in the area to be treated are another contraindication.

Some situations are not absolute contraindications but do require more careful analysis:

• Use of certain medications that interact with neuromuscular transmission.
• A history of allergic reactions to components of the formulation.
• Coagulation disorders or use of anticoagulants.
• Expectations that do not correspond to what the toxin can achieve in that specific case.

That last point deserves attention: there are patient profiles for whom botulinum toxin is not the most appropriate resource for the objective described. In those cases, the assessment establishes this clearly, and the options that do apply are discussed.

Adverse effects and signs that require immediate attention

The most common adverse effects are local and transient: redness, mild swelling, and bruising at the injection site. These are expected and resolve within days. Temporary drooping of the upper eyelid, known as ptosis, is an uncommon but documented adverse effect linked to diffusion of the product outside the application area.

Some effects warrant medical attention without delay:

• Sudden changes in vision after application.
• Difficulty breathing or swallowing.
• Generalized muscle weakness not present beforehand.
• Intense pain in the treated area with skin that changes color (white or purple).

If you experience any of these symptoms after a session, go to an emergency department immediately. Do not wait for a follow-up appointment or send a message to the clinic: these are signs that require urgent medical evaluation at that moment.

Clinical follow-up exists to adjust the protocol, not to handle emergencies. An emergency always goes to emergency care.

Botulinum toxin and hyaluronic acid: different resources, different logic

A comparison that comes up often in early research is botulinum toxin versus hyaluronic acid. They are not interchangeable or competing: they address different problems. The toxin acts on muscle contraction. Hyaluronic acid is a volumetric filler used to restore or add volume in areas where tissue has lost density.

There are cases in which both are used in a complementary way within the same protocol. That decision depends on the analysis of the area, the objective, and the medical assessment. Neither replaces the other, and the choice should not be based on what is trending, but on the indication.

What remains under investigation and what does not apply here

The aesthetic use of botulinum toxin in the forehead, glabellar area, and periocular region is the one with the strongest support and the longest follow-up in the medical literature. Other aesthetic applications, such as use in the neck, chin, lips, or the so-called Nefertiti lift, are described but with less uniformity in the available data. They are applied with clinical judgment, not as a standard.

What does not apply in this article: the therapeutic uses of botulinum toxin, such as the treatment of chronic migraine, bruxism, hyperhidrosis, strabismus, or muscle spasticity. Those uses exist and carry medical indication within their own specialties, but they involve different logic, dosage, and follow-up. This article is limited to the aesthetic scope.

Frequently asked questions about botulinum toxin

Are botulinum toxin and Botox the same thing?

Botox is a commercial brand of type A botulinum toxin, the first to obtain regulatory approval. In everyday conversation they are used interchangeably, but technically Botox is just one of several available formulations of the same molecule. What matters is the indication and the dosage, both defined at medical assessment.

What does botulinum toxin do on the face?

Its most documented aesthetic use is softening dynamic expression lines: forehead lines, glabellar lines, and periocular lines. It works by transiently relaxing the muscles that produce those lines. In deep static wrinkles the effect is smaller and depends on each individual case.

Who should not receive botulinum toxin?

It is not indicated during pregnancy or breastfeeding, or in people with neuromuscular diseases such as myasthenia gravis. Active infections in the area to be treated are also a contraindication. Other situations, such as the use of certain medications, require individual analysis at medical assessment.

How long does the effect of botulinum toxin last?

The effect is temporary and reversible. Duration varies according to the area treated, the dosage, individual metabolism, and each person's muscular activity. There is no universal duration: it is one of the factors reviewed at follow-up to adjust the protocol if needed.

How is the botulinum toxin dosage determined?

Dosage is defined at an individual medical assessment. Muscular anatomy, line depth, facial symmetry, muscle tone, and the person's objective are all analyzed. There is no fixed dosage table: the protocol is individual and provided in writing.

Assessment with medical criteria in Puerto Cancún

At Longevia Medical, located in Puerto Cancún, care begins with an individual assessment, in person or remote. That assessment determines whether botulinum toxin applies to the objective you describe, in which areas, with what protocol, and with what follow-up. The plan is provided in writing and care is conducted under medical supervision. If you are outside Cancún, follow-up continues when you return home.

For further reading on botulinum toxin from a patient health perspective, Mayo Clinic and MedlinePlus publish general access information on their portals.

If your research extends beyond botulinum toxin and you want to understand how to evaluate a regenerative medicine clinic before making a decision, the article on how to evaluate a stem cell therapy clinic in Mexico describes the criteria that distinguish a rigorous clinical setting from one that is not.